Magnesium sulfate administered via continuous intravenous infusion in pediatric patients with refractory wheezing.

Purpose: To evaluate the dosing and safety of intravenous magnesium sulfate administered via continuous infusion for refractory wheezing.

Materials And Methods: All patients admitted to the pediatric intensive care unit (PICU) between January 1998 and March 2001 who were prescribed magnesium sulfate via continuous infusion were identified via retrospective chart review. The patient's medical history, demographic data, vital signs, magnesium dosing history, and concurrent medications were recorded.